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Abstract 
Transcatheter Aortic Valve Implantation (TAVI) accounts for one of the most promising new cardiovascular 
procedures. This minimally invasive technique is still at its early stage and is constantly developing thanks to 
imaging techniques, computer science, biomechanics and technologies of prosthesis and delivery tools. As a 
result, patient-specific simulation can find an exciting playground in TAVI. It canexpress its potential by 
providing the clinicians with powerful decision support, offering great assistance in their workflow. Through a 
review of the current scientific field, we try to identify the challenges and future evolutions of patient-specific 
simulation for TAVI. This review article is an attempt to summarize and coordinate data scattered across the 
literature about patient-specific biomechanical simulation for TAVI. 
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Introduction 
 
Aortic Stenosis (AS) is a cardiovascular disease affecting the heart‘s aortic valve. Surgical aortic valve 
replacement (AVR or SAVR) is the current standard treatment. Unfortunately, it requires thoracotomy and 
cardiopulmonary bypass to reach and repair the damaged zone. These difficult procedures can be especially life-
threatening for elderly patients and require a long recovery period. Fig.1 shows a picture of an on-going AVR. 
 
 
Fig.1 AVR, surgical implantation of a bioprosthetic valve, cf  section 1 for more detail (reproduced with 
permission of Dr. Sukumar Mehta) 
 
Transcatheter Aortic Valve Implantation (TAVI) has emerged as a promising solution for AS treatment. This 
novel technique consists in delivering a bioprosthesis into the heart, through the patient‘s arteries. This 
minimally invasive procedure significantly shortens recovery time and can successfully treat inoperable or very 
high-risk patients. Indeed, TAVI has proven to be superior to AVR in such populations [1][2][3]. However, 
TAVI is a recent procedure, with the earliest implantations dating back to 2002 [4], leading TAVI prostheses to 
continue struggling to outperform AVR prostheses in various aspects [5]. Indeed, this method of treatment has 
been limited to high-risk patients due to numerous concerns, such as complications that are particularly difficult 
to deal with [6][7] and limited follow-up data about prosthesis durability. 
 
In order to predict the complications that may occur, a promising approach is taking into account the specific 
details of the anatomy and characteristics of arteries, as they can differ greatly from one individual to another. 
Therefore, patient-specific simulations are powerful tools in this context. There is little doubt that patient-
specific simulation will help TAVI expand its recommended patient population. Still, TAVI is challenging to 
model and simulate accurately. Patient-specific simulation studies only started a few years ago[8]. As a result, 
comparative studies on large-scale data are lacking and there is no reliable and proven model. Instead, those 
studies are dedicated to developing increasingly accurate models. This review article will shed some light on 
these advances. 
 
The first part of this review provides general information for readers who are unfamiliar with TAVI. It details the 
context of AS, the procedure of TAVI and the common complications that follow it. The second part will offer 
an overview of the evolution and new aspects in patient-specific simulation. The third part will look at the 
choices made in each study to model TAVI. The last part will expose how simulation results have been exploited 
so far. 
 
 
1. Clinical context 
 
This first section provides clarification about the general context of Aortic Stenosis (AS) and Transcatheter 
Aortic Valve Implantation (TAVI). It is mainly intended for readers unfamiliar with the cardiovascular field. As 
it expands the points in the introduction, readers may skip to the second section concerning patient-specific 
simulation. 
 
1.1. Aortic Stenosis 
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General considerations 
 
The heart pumps blood and guarantees the necessary blood irrigation across the human body. In other words, the 
heart provides mechanical energy to make the blood flow. Naturally, an obstacle in the blood vessels or failure 
of a component of the heart may dissipate this mechanical energy. The heart will be forced to compensate this 
energy loss to maintain adequate blood flow. This additional burden can exceed the heart‘s capacity and lead to 
heart failure. This is precisely the situation that happens in the case of AS. 
 
 
fig.2Left, aortic valve anatomy; right,upper view of fully open healthy and calcified valve during systole 
 
The heart includes four valves which are essential to its pumping function. In particular, the Aortic Valve 
separates the left ventricle from the aorta. Through three mobile leaflets, which open during the left ventricle 
contraction (systole) and close during the left ventricle relaxation (diastole), it maintains a unidirectional blood 
flow from the heart to the aorta. Then the aorta and further arteries lead to all the tissues that require blood: the 
heart itself, the brain, organs, muscles, etc.  
 
AS is defined by a decreased effective area of the aortic valve and is considered severe when this area is below 
1cm² or 0.6cm²/m²  [9]. It is the most common valvular disease with increasing incidence in aging population 
affecting almost 10% of octogenarians[10][11]. In a large majority of cases, this is because of heavy 
calcifications of its leaflets. Fig.2 shows how the calcified valve behaves in comparison to a normal valve during 
systole. In a way, AS is the apparition of an obstacle right at the start of the arterial system. From a fluid 
dynamic point of view, the flow cross-section (aortic valve area) of the blood is significantly reduced at the 
passage of the calcified aortic valve. The reduction of this area may cause a turbulent mixing phenomenon, 
which is depicted in Fig.3. It shows a side view of the aortic valve. The central jet velocity increases at the choke 
point as its pressure drops. Then, the central jet progressively loses velocity and recovers pressure. A portion of 
the central jet is redirected to the turbulent mixing zone, where part of the initial energy provided by the heart is 
dissipated into heat [12][13][14]. The turbulent mixing zone is at the interface of the central jet and the 
recirculation zone, where vorticities helps closing the valve at the end of systole. Lacking energy, the central jet 
may not recover enough pressure. From a clinical point of view, the patient would eventually suffer low cardiac 
output and low arterial pressure, as the remaining mechanical energy is insufficient to pump the blood to meet 
the body‘s needs. In practice, however, a compensation mechanism allows the heart to maintain adequate cardiac 
output through left ventricular hypertrophy before reaching heart failure. 
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Fig.3Side cut view of aortic valve. Dissipation of mechanical energy is mainly located in the turbulent mixing 
zone 
 
 
Symptoms 
 
AS has a slow onset as the heart can only tolerate reduction of the aortic valve area to some extent. Symptoms 
usually appear when AS is at a severe stage and quickly progresses thereafter [15]. Severe AS requires urgent 
treatment [16]. As previously stated, the heart eventually fails to provide the necessary mechanical energy to 
maintain an adequate cardiac output and end-diastolic left ventricular pressure rises. This situation is called 
congestive heart failure and can lead to a fatal outcome. The most common symptoms of severe AS are shortness 
of breath (dyspnea), chest pain and syncope typically during exercise but acute congestive heart failure 
(pulmonary edema) and even sudden cardiac death may also occur. 
Causes 
 
The main mechanism is the growth of calcifications on the leaflets known as degenerative AS which usually 
concerns the elderly. The calcifications stiffen the leaflets as they grow on it and hinder the opening and/or the 
closing of the valve. Another cause is the congenital defect known as bicuspid valve. The aortic valve possesses 
two leaflets instead of three, resulting in faster degeneration of the aortic valve. Indeed, bicuspid aortic valve 
alone is not sufficient to cause severe aortic stenosis by itself, but rather, accelerates the degeneration and 
calcification of the aortic valveleading to an earlier onset of aortic stenosis [17]. 
Standard treatment 
 
Surgical Aortic Valve Replacement (AVR or SAVR) is established as the gold standard for the treatment of AS. 
The surgeon accesses the heart through thoracotomy and cardiopulmonary bypass. The native calcified leaflets 
are removed and a prosthesis is sewn into the aortic root, cf Fig.1. TAVI prosthesis are limited to bio-prosthesis 
(leaflets sewn into a stent c.f. Fig.5), because the percutaneous access through arteries requires crimping the 
prosthesis to fit in the vessels (c.f. section 1.2).On the other hand, AVR prosthesis can have different designs that 
do not require to be crimped, thanks to the direct access to the heart through thoracotomy. Therefore, it is 
possible to implant mechanical valve with high structural durability that can outlast bio-prosthesis. However, 
mechanical prosthesis necessitates lifelong anti-coagulant treatments to prevent thrombosis. Such prosthesis is 
the bi-leaflet valve given in the Fig. 4-C. 
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Fig.4 AVR prostheses; A –face view of bioprosthesis; B –upper view of bioprosthesis; C - bi leaflet-mechanical 
 
 
The advantages of AVR are that the surgeon has total control over the tools, calcifications and position of 
implantation of the prosthesis. Additionally, this treatment is well documented and reliable as it has a long 
history of practice[20][21]. The burden on the patient‘s body and potential severe postoperative complications in 
elderly and often frail patients are the main weaknesses of this treatment. Thus, it is estimated that one third of 
patients cannot undergo this treatment because of high-risk comorbidities [10]. 
 Socio-economic impact 
 
The growth of calcifications is a relatively slow process and requires years to become life-threatening. Except for 
patients with bicuspid valves, it is usually elderly patients over 70 years of age who are concerned by AS. This is 
precisely the reason why AVR is not sufficient to face this disease. Elderly patients may suffer comorbidities and 
thus be exposed to high risks during open-heart surgeries. They would then require lengthy recovery times and 
follow-ups, inducing further costs for the hospital facilities. The cost of AVR intervention is around $26,900 
[22], however, the total cost of the treatment includes the hospitalization following the surgery. Therefore, the 
cost increases significantly for high-risk patients: from $106,277 (for non-high risk) to $144,183 over the course 
of 5 years, according to M. Clark et al.[23]. 
 
The increase of life expectancy also increases the prevalence of this disease in the general population [24][25]. 
As the proportion of elderly population steadily increases, the number of patients is expected to increase to 1.4 
million patients in North America by 2050[26]. Indeed, the authors applied the estimated prevalence of AS in 
elder patient population and applied it to prediction of the population evolution. Thus, it is crucial to find new 
solutions to treat the oncoming increase of patients more efficiently.It is estimated that 67,500 AVR were 
performed in 2010 in the United States [23]. A statistical study estimated that the number of severe symptomatic 
AS amounted to 540,000 in North America in 2013[26].  
 
1.2. What exactly is TAVI? 
 
A recent alternative to the AVR is the minimally invasive TAVI, Transcatheter Aortic Valve Implantation, 
sometimes called PAVR, Percutaneous Aortic Valve Replacement. Rather than removing the calcified valve, the 
goal of TAVI is to deposit a prosthesis (TAV) over the diseased leaflets. Examples of TAV are displayed in 
Fig.4. In order to deliver it onto the impaired valve, the prosthesis is moved through the artery. The prosthesis is 
crimped in a catheter to fit into the artery, hence the term Transcatheter. Thus, the procedure rests upon complex 
high-technology prosthesis which can change size. The two most popular models are displayed in Fig.5. 
Thorough review of new-generation prosthesis can be found in [27]. 
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Fig.5 TAV prostheses: left is SAPIEN (Edwards Lifesciences™); right is CoreValve (Medtronic™) 
 
TAVI can be used to treat inoperable patients, i.e. patients with chest malformation, repeated open-chest 
surgeries or serious underlying illness. For now, rather than directly competing with each other, both procedures 
are complementary, with their own strengths and weaknesses. To date, TAV durability is not well documented 
with only a few reports with a follow-up to 5 years post procedure. The PARTNER trial[2]showed that TAVI 
was superior to classic medical treatment and non-inferior to AVR for its 1-year all-cause mortality primary 
endpoint and the more recent CoreValve US PIVOTAL trial that enrolled patients at slightly lower risk, although 
still considered high risk, even demonstrated the superiority of TAVI over AVR for the same endpoint[1]. 
Currently, TAVI is only recommended for inoperable or high-risk patients, as assessed by a ―Heart Team‖ 
including interventional and non-interventional cardiologists, cardiac surgeons, anesthesiologists, geriatricians, 
etc. Nonetheless, TAVI offers room for improvement. Better reliability of TAVI would broaden the eligible 
population, lessen the burden on patients and potentially result in a lower financial cost in the long run. In order 
to observe the full scope of the hurdles encountered by TAVI, the following parts will describe the procedure. 
This will help with understanding the complications that can arise from TAVI. 
Setting up the guidewire 
 
The procedure involves steering tools through sinuous arteries to the valve location. Once a stiff guidewire is set 
up into the left ventricle, the tools are easily brought on a catheter gliding over the guidewire. The guidewires are 
preferably inserted through the femoral artery but TAVI may be performed by sub-clavian, carotid, direct aortic 
and transapical approach, as seen on Fig.6. There is a recent increase of prosthesis models, some of them are 
specialized for a specific type of approaches, such as Engager (Medtronic™)which is specifically designed for 
transapical approach[27].  
 
Fig.6 Map of vascular access for TAVI 
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Predilatation 
 
Once the stiff guidewire is inserted into the left ventricle, it is possible to deploy the prosthesis. However in 
some cases, the calcified aortic valve does not allow the prosthesis passage. In order to force the valve opening, a 
predilatation is usually performed. This step is called aortic valvuloplasty or balloon valvuloplasty. A balloon is 
brought to the calcified valve and expanded as shown in Fig.7. 
 
 
Fig.7 X-ray fluoroscopy of a patient undergoing predilatation 
 
The pressure at the heart output is so high that deploying a balloon without precaution may tear the heart valve 
and damage the aorta. Hence, it is necessary to suspend the blood flow with ―Burst stimulation‖. The heart is 
stimulated at a very high rate by a temporary pacemaker introduced in the right ventricle through the femoral 
vein. The heart twitches uncoordinatedly without pumping blood, allowing balloon deployment. 
Prosthesis Deployment 
 
The two most popular TAVI prostheses worldwide are SAPIEN (Edwards Sapien, Edwards Lifesciences, Irvine, 
CA, USA) and CoreValve (CoreValve, Medtronic, Minneapolis, MN, USA). These devices are displayed in 
Fig.5. Those two prostheses have different deployment mechanisms. SAPIEN is balloon expandable, meaning a 
balloon deployment is necessary to implant it. Another burst stimulation is required during this step. The 
deployment is fast but the position cannot be corrected once it begins. CoreValve is self-expandable, it adopts its 
final shape as it is released from the sheath. The medical team releases CoreValve progressively (10%, 25%, 
50%, etc.) and continuously adjusts its position during the deployment which may still be challenging because of 
difficulties to predict the final position of the prosthesis once deployed. 
 
Whichever prosthesis is chosen, it is brought to the middle of the native valve along the guidewire. When the 
medical team is ready, the prosthesis is unsheathed and carefully deployed. While this procedure sounds 
promising, some challenges remain. Its performance is still uncertaincompared to AVR for non-high risk patient, 
while its current operation cost is far higher[22]. Complications following TAVI exist and increase the mortality 
rate. It is critical for the development of TAVI that the cost of the devices decreases and that its complications 
are addressed. 
 
1.3. TAVI Challenges 
 
Thanks to the efforts of Cribier et al.[4],the first TAVI was executed in 2002. However, 13 years of evolution in 
procedures, prosthesis, and delivering tools are too limited to completely erase complications. This part lists the 
main complications encountered in the TAVI procedure reported[7].  
Positional shift 
 
AVR allows total control of the tools, the implantation site and the anchoring of the prosthesis by the surgeon. In 
the opposite case, tools in TAVI are remotely inserted in a way that offers little control for the operator. 
Concretely, the AVR surgeon can precisely cut the aorta to position the prosthesis, while TAVI only allows for 
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the length of insertion for the prosthesis deployment. As a result, the prosthesis can shift during its implantation. 
An experimental study  showed the SAPIEN shift longitudinally during deployment[28]. Although minor for 
most cases, a significant shift can unexpectedly occur and lead to complications [29]. It must be noted that 
different models of stent induce different shifts. It was observed that SAPIEN 3 and the former version SAPIEN 
XT do not behave the same way[30]. 
 
Moreover, the angle of deployment and the shift between the center of the aortic valve and the prosthesis prior to 
implantation are difficult to control. Fig.8 shows a TAV in a slanted starting configuration for deployment. It 
may be difficult for inexperienced teams to accurately predict the outcome of deployment. Hence, one of the 
major issues of TAVI is the positioning reliability of the prosthesis inside the native valve. Because of an 
unreliable control of the implantation, this can lead to a variety of different complications. 
 
 
Fig.8 Misaligned starting position of TAV for the deployment in two different patients receiving a SAPIEN™ 
 
 
Coronary occlusion & Migration 
 
 
Fig.9 Heart with highlighted aorta and coronary arteries (illustration from Patrick J. Lynch) 
 
Coronary arteries supply the heart with blood. They begin in the aorta, few millimeters,around 12 mm on 
average, above the valve as seen in Fig.9[31]. A misplaced prosthesis may block the coronary, which will lead to 
myocardial infarction. Coronary occlusion also occurs when the calcified native leaflet shifts towards the 
coronary artery [32] or when a calcification migrates into the coronary [33]. Migration of TAV can also happen 
due to misplacement, either into the aorta if the prosthesis is deployed too high, or into the left ventricle when 
excessively low [29]. 
Mitral valve injury 
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The mitral valve is right beside the aortic valve, c.f. Fig.2. It has two leaflets which are linked to papillary 
muscles on the heart wall. The ―super stiff‖ guidewire placed in the ventricle may injure the mitral valve or its 
muscles. Low prosthesis may also hinder the mitral valve, and cause serious degradation to it [7]. 
Atrioventricular block 
 
A nerve network is spread through the heart, allowing polarization of the heart muscle and triggering the heart 
contraction. If the prosthesis is too low, it may lead to atrioventricular block, which is a disturbance of the nerve 
network, and induce conduction abnormalities. In this case, the patient needs a permanent pacemaker. This 
complication happens more often in TAVI than in AVR and three time more often in CoreValve than in SAPIEN 
prosthesis[34]. This is an additional cost because this complication can appear up to 6 days after the intervention, 
prolonging the duration of hospitalization for monitoring. 
Prosthesis mismatch 
 
AS is a decrease of the opening valve area. The goal of TAVI is to restore the valve area. However, a small 
enlargement of the opening area may not bring significant benefit to the patient. Sometimes, the overall impact 
of the TAVI can be negative instead of alleviating the patient‘s situation. Those situations are referred as 
prosthesis mismatch. It is a significant problem when implanting a new prosthesis inside an already existing one 
(valve-in-valve maneuver) or a bicuspid valve [35]. The prosthesis functional area will be smaller than the 
maximum aortic valve area of the anatomy. Also, the prosthesis may not be fully deployed inside bicuspid 
valves. Otherwise, mismatch still remains a rare occurrence compared to classic surgery[36][37]. Prosthesis 
mismatch can also occur when the chosen prosthesis is undersized. However, an oversized prosthesis may result 
in other problems, e.g. aortic injury. Hence, the expertise of the medical team is crucial to determine the best 
compromise limiting the risk of complications. 
Aortic injury 
 
The aortic root containing the valve may rupture following the implantation of the prosthesis. This complication 
is particularly difficult to study because of its low frequency (~1%) and many types of rupture can arise [38]. 
Aggressive oversizing of the prosthesis was said to be related to this [6]. However, Hayashida et al.[39] 
suggested that the calcification layout on the aortic root is a strong reason for the aortic rupture[39]. Indeed, 
dislodged calcification may push vulnerable area of the aortic root. 
Leaks 
 
Paravalvular leaks remain a big hurdle in TAVI. They are less likely to occur during AVR. Leaks cause 
regurgitation which burdens the heart and may be correlated with long term prognosis and late mortality [40]. In 
engineering concepts, leaks contribute to significant energy loss in diastole [5][35]. Much like the previous 
complications, paravalvular leaks may be related to an inadequate sizing of the prosthesis, as oversized 
prostheses are said to reduce leaks [7]. The stent must adapt to the shape of the aorta wall. This depends 
significantly on the calcification scattered on the native valve. As the leaflets are designed to open and close 
correctly when totally circular, the stent must also be as round as possible to prevent a central leak [41]. 
 
There are different types of leaks, which are represented in Fig.10[42]. Transvalvular leaks come from an 
insufficient coaptation of the prosthesis leaflets. In other words, the leaflets do not seal the valve because gaps 
appear between the leaflets. It may happen when the deployed stent is not circular enough [43]. Paravalvular 
leaks appear from the gaps between the stent and the aortic wall. Lastly, supra-skirtal leaks occur in a similar 
way as paravalvular leaks. A skirt is sewn on the stent frame of the prosthesis to seal the gap between the leaflets 
and the stent. However, if the prosthesis is placed too low, the skirt does not fulfill its function. 
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Fig.10 Side section of a leaking TAV; left, transvalvular leak; middle, paravalvular leak; right, supra-skirtal leak 
[42] 
Calcification migration 
 
Embolic stroke is one of the main concerns of TAVI. During the insertion of delivery tools, the thick catheters 
may dislodge calcification from the aorta. Besides this, during the balloon dilatation or prosthesis deployment, 
the native valves are crushed and will release calcific debris which may migrate to the brain [44]. Hopefully, 
new devices such as embolic filters may reduce these complications [45]. Claret Medical‘s device, Sentinel, has 
received approval for the American market. Studies to evaluate its performance are still ongoing. 
Financial challenge 
 
TAVI has quickly been adopted across 40 countries. It is estimated that over 50,000 TAVI procedures had been 
performed since 2002 [46]. However, the current market of TAVI prosthesis is extremely limited. The few 
available models are costly. Currently, the performance of TAVI does not justify the healthcare expenditure for 
non-high risk patients [22]. Lowering the cost and improving the performance of TAVI are necessary steps to 
broaden its use. 
 
Current medical research is focused on preventing those complications. Patient-specific simulation is a very 
relevant path to explore in order to predict the complications. The next part reviews the TAVI finite-element 
models that have been created so far and how they can help clinical workflow. 
 
2. State of the art   
2.1. Beneficial impact of patient-specific simulations 
 
TAVI has yet to overcome the problems described in the previous section. It has a strong potential because it can 
treat a broader population than AVR can. Also, the minimally-invasive procedure itself leaves the patient in a 
better condition than patients recovering from thoracotomy. However, TAVI cannot guarantee total relief of 
aortic valve dysfunction. In such cases, the degradation of the patient‘s condition does not stop and leads to 
further hospitalization. We can distinguish two ways to overcome complications. One way would be the 
improvement of the TAVI procedure itself. This can be achieved through various ways such as the development 
of prostheses, delivery tools, tracking tools, and imaging devices. 
 
Some anatomies are more prone to complications than others. Therefore, another aspect to improve on is the 
planning and patient selection criteria in order to reject those with high risk anatomies. Accurate selection will 
help to make the best out of TAVI by treating patients who require minimally invasive intervention while 
avoiding high risk patients. Thanks to the continuous medical research in TAVI, the sources of complications are 
better understood. In vitro, in vivo and numerical simulation clarified many phenomena [47]. In practice, those 
problems are very difficult to avoid, as their mechanisms cannot be fully handled with current decision support 
tools. Some patients who seem perfectly fine to receive TAVI turn out to be problematic cases, e.g. aortic 
rupture [39]. In other words, despite a better understanding of the phenomena, complications still remain highly 
complex problems. Thus, the knowledge of complications cannot be easily generalized. It is of utmost 
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importance to study case-by-case complication risk. The medical team handling the surgery needs strong 
expertise of TAVI to ensure success. Large differences were reported between inexperienced, beginning medical 
teams in comparison to experienced ones [48]. Moreover, different models of prostheses behave differently. 
Medical teams experienced with one TAV model may not easily use another one. For all those reasons, medical 
teams can benefit from quantitative tools to aid the surgical planning, assessing and comparing AVR and TAVI 
postoperative performance. 
 
Different approaches are available to predict risk. The statistical risk assessment can prove to be a helpful 
decisional tool as it can provide risk scores to predict failure of intervention. Statistical risk models are 
developed using post-data results of previous intervention. For instance, Euroscore is aninternationally used risk 
model to evaluate the risk of death after heart surgery, and uses a manageable amount of parameters such as age, 
gender, comorbidities, etc. Risk scores can also be applied to TAVI [49]. In the end, risk scores provide limited 
information about the type of complication and how it may be solved. Though risk scores are an asset to spread 
the use of TAVI, it does not invite development in complication management. Moreover, statistical models are 
restricted in the amount of input parameters, and as previously said, complications are difficult to generalize. 
Another drawback is the evolution of tools and prosthesis type. It is safe to assume that the quality of prosthesis 
models may impact the risk. Then, new models cannot benefit from statistical risk assessment since post-op data 
would be non-existent. 
 
On the other hand, numerical simulations take into account intricate input data and can offer a better grasp of 
complications. Thus, this method can provide finer risk assessment than statistical risk models and better insight 
on the complication mechanisms.  
2.2. Chronology of TAVI simulation 
 
Papers concerning TAVI and aortic valve simulation were primarily retrieved from PubMed and Google Scholar, 
using the keywords: Transcatheter Aortic Valve Implantation simulation, Finite Element Aortic Valve, Fluid-
structure Aortic Valve. Additionally, backward and forward snowballing was performed to extend the 
bibliography. Some of the following studies are not patient-specific. However, those models of simulation may 
be adapted to patient-specific geometries to design a patient-specific planning procedure. Papers closely 
concerning TAVI are reported in tab.1.  
 
We can observe an increase of numerical simulation studies concerning TAVI during the last decade. We found 
that the first simulation study concerning TAVI prosthesis was made by Dwyer et al. (2009) to characterize the 
blood ejection force that can migrate the prosthesis[50]. However, the first study using patient specific data for 
TAVI was proposed by Sirois et al. (2011)[8]. Though numerical study of TAVI is recent, the use of simulation 
had already been developed in numerous applications. For instance, studies about kinematics of native aortic 
valve greatly helped TAVI studies. Some of the relevant studies remotely concerning TAVI are reported in tab.2. 
 
 
Fig.11 Different stage of TAVI procedure 
 
TAVI simulation studies usually concern only one step of the procedure. Fig.11 summarizes the main steps of 
TAVI. As the previous table reports it, most of the papers focus on the prosthesis deployment step. This is a 
critical step because it predicts the final prosthesis configuration. Indeed, most complications are dependent on 
how and where the prosthesis is anchored in the aortic root. A realistic deployment simulation should take into 
account input data such as prosthesis configuration prior to deployment. Anticipation of the prosthesis behavior 
during this critical step is greatly beneficial for medical teams. Currently, they have to choose the starting 
position of the deployment without any certitude regarding how the prosthesis will behave during implantation. 
However, no simulation study has been done yet on the insertion of tools and prosthesis starting configurations. 
 
Even though simulations are not advanced enough to predict where the prosthesis will land depending on the 
starting position yet, they can provide invaluable insight on possible outcomes and optimal prosthesis sizing. 
Additionally, final prosthesis configuration is a preliminary input for the following step, which consists in 
simulating the prosthesis function in the patient anatomy. The goal of the next step is the hemodynamic 
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assessment for the performance of the valve. This can help choosing the best procedure between TAVI and 
AVR. It would also be possible to find the optimal final position of the prosthesis. Indeed, Groves et al. 
[62]showed that the position of the prosthesis impacts the quality of hemodynamics such as blood velocity and 
coronary perfusion[62]. 
 
The deployment of balloon-expandable TAV is mainly a structural problem, where blood flow can be neglected 
thanks to burst stimulation and the speed of the deployment. As a result, published studies largely exploit Finite 
Element Method (FE) in order to simulate the prosthesis‘ expansion. On the other hand, neglecting blood flow is 
a less obvious choice for self-expanding TAV, as its deployment is slow and the TAV is liable to slightly 
migrate with blood pressure. In this case, methods encompassing blood flowmay be considered. For instance, 
CFD simulation (Computational Fluid Dynamic) can simulate the blood flow. It seems that there is a strong 
interaction between the blood and valve as it pushes the leaflets. Therefore, a strong coupling is needed between 
the fluid aspect and structural aspect. A relevant approach is FSI simulation (Fluid-Structure 
Interaction).Moreover, the complex mechanical behavior of a self-expanding stent is an additional challenge for 
researchers. Very few studies concern self-expanding TAV for now, but more is expected to come. Indeed, a 
large proportion of new prosthesis models are using self-expandable technology : CENTERA, Acurate, Jena 
Valve, Portico, UCL TAV, Foldavalve, etc [63][27]. 
 
When prosthesis deployment is successfully simulated, studies attempt to extract useful criteria in order to 
estimate the prosthesis performance. Simple criteria can be assumed from the deployment data, e.g. stresses, 
strains and shape of the stent and leaflets. However, they remain too limited to reliably predict performance. As a 
result, some papers tackle the next step, following the deployment step. Sirois et al. [8]were the first to suggest a 
CFD simulation after FE deployment to characterize the blood flow. Auricchio et al.[57] performed another step 
to close the valve through FE simulation[57]. In both studies, the movement of the leaflet was obtained through 
FE simulation and originated from uniform pressure upon the leaflets, instead of the action of the blood. This 
type of model is called ―dry‖ model as it replaces fluid by prescribed pressure. 
 
However, FE simulations may fail to reproduce the complete in vivo behavior and thus provide inaccurate data. 
A more exhaustive type of simulation would be Fluid-Structure Interaction (FSI) as it couples fluid mechanics to 
structural analysis. FSI techniques are still maturing in order to study healthy native aortic valve behavior, but 
numerous results and hypothesis can be applied again to TAVI simulations since those healthy valve models are 
very advanced. Results from those studies that can be applied to TAVI are reported in tab.2. 
 
FSI has not been fully implemented in the context of TAVI yet. One exception is the study by Kemp et al. [56], 
which studies a custom-designed TAV prosthesis. Even though careful consideration of the fluid through CFD or 
FSI is a reasonable idea, current models might be insufficient to provide reliable data, as Sotiropoulos et al. and 
Stewart et al. pointed out[64][65]. As FSI progresses, we can expect FSI studies of TAVI performance to appear. 
Still, it is not clear whether the FSI gain in accuracy for hemodynamic assessment can justify the computational 
cost, but FSI is used more and morein applications such as mechanical aortic valve prosthesis [66]. 
3. Method of simulation 
 
In this section, various aspects needed to define simulations are reviewed. Main points of those different aspects 
have their dedicated part: meshing the valve, mechanical properties of the tissues and boundary condition. For 
readers seeking complementary points of view on heart valve simulation, reviews from W. Sun et al., G. Marom 
et al., Votta et al., Tseng et al. can be particularly useful[89][90][66][47]. 
 
3.1. Geometry 
 
Imaging challenges 
 
Simulation studies have shown that geometry can significantly impact the results. In particular, it was found that 
asymmetry in geometrical configuration of the leaflet impacts the leaflet stress, and consequently, the valve 
durability [68]. It has been shown in numerous studies that the sinus of Valsalva also influences stress 
distribution for both the aortic wall and leaflets [69][77][79]. In addition, the aortic wall deformation 
significantly participates in the valve opening [70][71]. All this evidence concurs on the importance of accurate 
13 
 
geometry representation of both the aortic wall and leaflets. However, accurate imaging of the leaflet and aortic 
wall is challenging because of its motion throughout the cardiac cycle. Therefore, imaging techniques and image 
processing knowledge play a large role in the extraction of patient-specific anatomy. Indeed, image processing is 
required to extract relevant elements from patient anatomy. For instance, the pulmonary artery usually overlaps 
with the aorta. This can disturb the extracted valve geometry. 
 
Several imaging techniques are available in clinical practice, such as echocardiography or magnetic resonance 
imaging (MRI). Currently, the main technique being used to obtain 3D geometry for TAVI simulation is the 
multi-slice computed tomography (MSCT or CT). On the other hand, FSI simulation usually prefers MRI, as it 
may also provide fluid data (4D MRI flow imaging). Even though echocardiography is widely used clinically to 
assess valvulopathy, 3D echocardiography has poor spatial resolution and is not sufficient for geometrical 
reconstruction alone.  
 
Before a TAVI, patients usually undergo a CT scan for the planning of procedure. Because classic CT scans are 
not instantaneous, they fail to grasp the quick movement of the leaflets. However, ―Gated CT scans‖ are 
synchronized with the ECG (electrical heart activity). Those scans allow accurate representation of the leaflets at 
a specific phase of the cardiac cycle, provided the patient ECG is regular. Those synchronized scans allow finer 
3D reconstruction of the anatomical architecture of the patient. However, the drawback of CT scans is the 
radiation exposure and nephrotoxic contrast media injection in the patient. 
 
Aortic wall & native leaflet reconstruction 
 
Numerical simulations of TAVI opted for CT scans, but there is no agreement on the extraction method. We 
report numerous different software: VTK, Mimics (Materialise, Leuven, Belgium), Avizo (VSG, Burlington, 
MA), ITKsnap etc. Tab.3 reports in the second column the image processing software used in various studies. It 
is difficult to automatically extract the fine details of anatomy, such as leaflets, even though synchronized CT 
scans offer good quality. Therefore, most studies manually traced those parts, or used geometric reconstruction 
from landmarks. Capelli et al. [51] and Wang et al. [58] extracted the native leaflets directly from CT. However, 
Capelli et al.[51]mentioned the difficulties and the efforts required to extract them. Indeed, Osirix and Avizo are 
both general segmentation software, but require expertise from the operator. This is why imaging processing 
techniques are crucial to introduce patient-specific simulation in the clinical field as an easy-to-use planning tool.  
 
Studies used various phases of the cardiac cycle, usually either at peak systole or peak diastole, when the motion 
of the leaflet is minimal. Capelli et al. [51] and Wang et al. [52]reconstructed the leaflet in its systole phase[52]. 
Wang et al. [58]used diastole instead. It is worth noting that Morganti et al. [59]reconstructed the native healthy 
leaflet from manual landmarks, and projected calcifications upon it. Indeed, at the start of the simulated 
deployment, the native leaflets were completely open. However, it was open well beyond the case of a severe 
aortic stenosis. The starting configuration should be stress-free, meaning that the effort to push the calcified 
leaflets open may have been underestimated. 
 
After extraction of the geometry, it is necessary to produce a proper mesh for calculation. Other software is 
usually needed. This step can either be made on dedicated meshers like ICEM CFD (Ansys, Inc., Canonsburg, 
PA, USA) and HyperMesh (Altair Engineering, Inc., MI) or on solver preprocessors such as Abaqus (Simulia, 
Dassault Systems, Providence, RI, USA). Aortic wall and calcification are often meshed with tetrahedral 
elements while leaflets are usually meshed with quadrilateral shell elements with reduced integration. 
Zero-pressure issue 
 
In simulations, the initial input geometry of the model should often be in a stress-free state. However, it is 
important to keep in mind that the scanned anatomy is physiologically loaded, as the artery bears the systemic 
arterial pressure and other loads. Therefore, the scanned geometry of the patient taken as such in the simulation 
would be inaccurate, because this geometry is actually the result of loadings while the simulation model should 
consider it as unloaded. Some studies transformed scanned geometry to find the state of the valve without blood 
pressure. This state is often referred as the ―no-load‖ state or ―zero-pressure‖ state.  This state can be achieved by 
excising the aortic valve out from the subject.  
 
Some FE studies suggested exploiting the zero-pressure state[52][81][82]. Wanget al.[52]proposed a 
straightforward method to determine the zero-pressure state. Experimentation has been made to determine the 
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relationship between the aorta diameter and blood pressure. Labrosse et al. [82] used a mathematical model for 
the geometry of the aortic valve and dimensions of the unpressurized aortic valve provided by prior experimental 
studies [91]. Conti et al. [81]used a mathematical model as well. However, the dimensions of the model were 
identified from their MRI data. The mesh from MRI data underwent an iterative algorithm to identify the zero-
pressure dimensions. 
 
However, arteries and valves may also be subject to complex internal stress. It was found that radially cutting 
arteries will make them spring open[92]. Such configuration is referred as the ―no-stress‖ state. W. Huang 
showed that the inner wall of arteries is in compression and that the outer wall is in tension[93]. Zhao et al. 
showed how the no-stress state impacted simulations data[94]. X. Huang et al. suggested a method to compute 
the no-stress state, proving the feasibility of computing no-stress configurations[95]. However, simulation 
studies concerning TAVI have not exploited no-stress configuration yet.  
Calcifications 
 
Another geometrical detail that is difficult to grasp, yet which has crucial importance, is the calcification. 
Synchronized CT-scan may provide a precise layout of the calcifications. There are different possibilities to 
represent them in the mesh. Capelli, Morganti and Wang modeled calcifications as ―zones‖ projected onto the 
leaflet, c.f. Fig.12 (left)[51][59][52]. The reconstructed native leaflet geometry is overlapped with CT-scan 
containing calcification data as described in [59]. It is assumed that the calcifications intersect the valve 
geometry and give the positions of calcific shell elements.These calcified zones were thicker compared to a 
healthy leaflet, as if calcification grew from both sides of the leaflet. In other words, a calcified zone 
encompassed both the normal leaflet layer and its calcifications. Calcifications on the aortic wall were ignored in 
the study[51], however they might be relevant as the aortic wall has been shown to participate to valve opening 
[70]. Although Wang et al.used such equivalent zones (leaflet+calcification) in their first study [52], 
theyconsidered the calcifications as separate from leaflet in their next study [58].Indeed,they hypothesized that 
calcification did not have fixed thickness and grew on one side of the leaflet, c.f. fig.12 (right). Also, Wanget al. 
projected calcifications on the aorta. Similar method was also previously applied by Russ et al, where segmented 
calcification elements were tied to the closest element by constraint [54]. 
 
 
Fig.12 Calcification models; left is used in most studies; right is used by Russ et al. and Wang et al. [54][58] 
 
The level of description of calcified aortic valve undoubtedly requires further study. Another question about 
anatomy is how much of the surrounding tissues should be modeled. Indeed, the aortic valve is connected to the 
ventricle below, and connected to the aortic artery above. Wang et al. [52]suggested including a part of the 
myocardium into the simulation. However, no subsequent studies followed this recommendation. 
 
TAVI tools 
 
Depending on the simulated step (tool insertion, deployment or post-deployment) and the hypotheses, different 
tools should be modeled. Most studies focus only on the deployment stage, which does not require the prosthesis 
leaflets. All papers reported about TAVI reconstructed at least the prosthesis stent. As it was stated previously, 
and also reported in Tab.3, most studies focused on the Edwards SAPIEN (Edwards Lifesciences, Irvine, 
California). As of today, the SAPIEN is the only available balloon-expandable prosthesis. 
 
So far, CoreValve (Medtronic Inc., Minneapolis, Minnesota) stents are included in few studies [53][54][61]. 
These studies proposed an accurate mathematical model for the geometry. It has been reused by Tzamtzis et 
al.[55]. Lastly, a generic self-expandable stent has been designed by Gunning et al.[60]. This new model was 
motivated by the fact that many new commercial devices use this mechanism.  
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In both TAV prostheses, leaflets were sometimes modeled. The usual approach is defining the leaflet through a 
mathematical model, and morphing it to adapt to the stent [57]. 
 
In the case of a balloon-expandable stent, the balloon should be modeled as well. In most cases, it is modeled as 
a simple rigid cylinder whose nodes are constrained to expand. There are some exceptions, however, as 
Auricchio et al. and Wang et al. modeled the balloon with a realistic geometry[57][58]. 
 
Summary 
 
While zero-pressure and no-stress states might be important in Abdominal Aortic Aneurysm for accurate 
prediction of aortic rupture [96], no study has proven its importance in the context of TAVI yet. Grande-Allen 
(2000) suggested the hypothesis that the residual stress was negligible in comparison with the valve and root 
stresses, and so far no study has challenged it[69]. Another notable point of the geometry section is the lack of an 
automated method to extract patient-specific geometry. Leaflet and valve extraction is an image processing 
technique and an image processing question that has no definite answer yet. Because of the small size and the 
transient nature of those details, they are difficult to extract from scans. Efforts are currently made to automatize 
the extraction of patient-specific geometries[97]. Some studies explore the use of parametric models whose 
dimensions are fitted with image recordings. For instance, Haj-Ali et al. &Rankin et al. suggested various 
parametric models[98][99]. Zheng et al. & Pouch et al. elaborated methods to extract leaflets[100][101]. In the 
study from Mansi et al.[102], an automated method can accurately extract the mitral valve.The spread of these 
fully automated tools is a necessary step: Not only would it make patient-specific simulations easy-to-use for 
medical teams, but it could also help exploit large patient data sets for validation studies. So far, no study has 
used such tools yet, but we can expect new studies featuring new methods in the future. Additionally, the use of 
patient-specific simulation in the clinical framework raises the issue of computational time and model 
complexity. The complexity of the model should not induce an impractical, long duration of computation in 
order to meet the clinical needs. However, the current stage of development of numerical simulation is not 
advanced enough to tackle this issue.  
 
3.2. Mechanical properties 
 
Detailing constitutive equations of each material model is beyond the scope of the present review article. 
Readers are referred to the review articles for a general description of the different material models widely used 
in simulations[90][89]. A short explanation is given in the following section. 
Aorta & leaflets 
 
We can observe different types of constitutive mechanical models. Linear elasticity (LE) is a model where 
stresses and strains are linearly related. A typical stress-strain curve is straight as shown in Fig.13 left. Linear 
elasto-plasticity (EP) is a model where the material can have permanent deformations. Tab.4 reports the different 
material models used for the aorta, leaflet, calcifications and prosthesis in the studies related to TAVI simulation. 
Concerning non-linear elastic behavior, several models are available. Hyperelasticity (HE) is a more complex 
model where the stress is related to strain energy density. It is often used to model non-linear elastic stress-strain 
responses, as shown in Fig.13 right.Another class of models used to describe soft biological tissues are the 
models based on the law of mixture (composite or mixture theory). Those multi-layered models take into account 
the contribution of all the structural constituents in the mechanical behavior of the material (elastic fibers, 
smooth muscle cells, fibrillar collagen). Those models are commonly applied in cardiovascular mechanics 
[103][104][105][106]. 
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Fig.13 Mechanical models used in numerical simulations for TAVI 
 
All the studies agree that anisotropic and hyperelastic models are required for biological soft tissues in TAVI 
simulations. Russ et al. compared rigid, linear-elastic and hyper-elastic isotropic models in a special deployment 
simulation[54]. Despite the fact that the hyperelastic model is supposed to have the highest accuracy, the 
difference found with a linearized elastic model seems negligible given the conditions of the deployment (5.5% 
deformation error from hyper-elastic versus 5.8% for linear-elastic). A simplifying hypothesis can reasonably be 
adopted. Because aortic root does not significantly deform during implantation, linearization of the material 
properties seems viable. Proper linearization requires finding the adequate level of loading on the aorta during 
implantation and using the corresponding Young‘s modulus, as seen in Fig.13 (right). 
 
The use of hyperelastic laws may emphasize the sensitivity of simulations to the lack of zero-pressure state. 
Indeed, hyperelastic model of soft tissues shows a small stiffness at very low strain (horizontal slope) and high 
stiffness at higher strain (steeper slope). Therefore the mechanical response of hyperelastic material changes 
significantly depending on its level of strain. However, we have seen in the previous section that the geometry, 
taken as it is, has an initial loading in the patient. This load induces a pre-strain that increases the stiffness of the 
aortic wall, if the physiological configuration is erroneously used as a zero-pressure configuration. Surprisingly, 
among the papers using hyperelastic constitutive models for the aortic wall, only Wang et al. [52] explicitly 
computed the zero-pressure state of the aortic valve. Then again, other aspects of simulation models that need 
better adjustment may have a stronger impact on the simulation. Therefore, the development of zero-pressure 
models in the context of TAVI might not have the highest priority so far.  
 
The TAVI simulations that take the native leaflets into account often use the same model for both the aortic wall 
and the leaflets. In opposition, it is common in FSI studies to use a linear elastic model for the aortic wall and a 
hyperelastic one for the leaflets. As a matter of fact, biological material models were an important aspect in 
studies for dynamic analysis of aortic valve behavior. This is understandable given the importance of native 
leaflets in the latter type of studies, which are precisely focused on the motion of the leaflets. Indeed, some 
TAVI studies do not even take native leaflets into account. In the case they do, the native leaflets end up tightly 
crushed by the stent. The anisotropic model appeared relatively late in TAVI studies compared to dynamic aortic 
valve studies. Auricchio et al. [57]& Wang et al. [58]are the first TAVI simulations to propose an anisotropic 
hyperelastic model. The aorta is represented as a composite material including 2 families of fibers [110]. 
Moreover, a failure criterion based on maximum stress for rupture was implemented.  
 
Meanwhile, concerning studies about the motion of leaflets, De Hart et al. and Driessen et al. thoroughly tested 
the fiber-reinforced anisotropic hyperelastic material model for the leaflets[74][114]. Marom et al. studied the 
impact of assigning different material parameters between the three leaflets[86]. Koch et al. compared various 
constitutive material models[83]. Four cases were tested: isotropic linear elasticity, transversely linear elasticity, 
isotropic hyperelasticity and transversely hyperelasticity. The limitation of those studies lies in the fact that a 
perfectly healthy aortic valve is considered. In the case of patient-specific simulation, the incertitude on the 
material parameter may be more impactful compared to the type of material model chosen. 
 
Calcifications  
 
Capelli et al.[51] and Morganti et al. [59]considered calcified zones, the calcified zone material being an 
equivalent model which encompasses the leaflet and the calcification characteristics. Thus, they used a linear 
elastic material, stiffer than a healthy leaflet and less stiff than pure calcification. Young‘s modulus (10 MPa) 
was chosen according to Loree et al.[115]. Capelli et al.[51]also suggested a method to represent the effect of 
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calcification against the opening of the valve. The calcified nodes at the junction between the leaflet and the wall 
were completely tied. However, a limit on maximum stress induced a rupture of this junction and the leaflet may 
deform more easily. 
 
Both studies from Wang et al.[52][58] used linear elastic model. The first study used calcified leaflet zones but 
included a very stiff material model (Young‘s modulus of 60 GPa). This choice is based on the study of 
Ebenstein et al.[108] that reported high elastic modulus from nanoindentation experiments. It seems reasonable 
that the material model obtained from nanoindentation relates to a relatively ‗pure‘ calcification. However, that 
choice would seem more appropriate in the second study of Wang et al.[58], where the leaflet and calcifications 
are separate entities. Instead, Wanget al.[58]used a stiffness (Young‘s modulus of 12.6 MPa) based on another 
study [111]. 
 
Prosthesis 
 
Edward‘s SAPIEN series are balloon expandable models. The former stents are made in stainless steel. Tzamtzis 
et al.[55]used a linear elastic-plastic to represent X2 CrNiMo-18-15-13 alloy. However, the latest models (e.g. 
SAPIEN 3) include a cobalt chromium frame. Morganti et al. [59]used updated mechanical characteristics for 
the cobalt chromium alloy. 
 
On the other hand, Medtronic‘s CoreValve series is a self-expanding prosthesis. Its mechanical behavior is very 
complex, as it depends on its thermo-mechanical history. CoreValve complexity is not popular in patient-specific 
simulations, since most of them feature the Sapien prosthesis. Still, Russ et al. simulated the deployment of a 
CoreValve stent[54]. However, the study assigned it a linear elastic-plastic behavior. Tzamtzis et al. [55]made a 
set of mechanical experiments to determine the mechanical response of CoreValve in a 37°C environment. He 
considered a complex mechanical model for NiTi material, which was developed by Auricchio et al. [116]. 
Gunning et al. simulated a realistic self-expanding stent deployment[60]. They applied the same material model 
on a custom-designed stent from the study by Tzamtzis et al.[55]. 
Friction 
 
Apart from constitutive material models, it may be necessary to define the friction behavior between the different 
parts of the model. Indeed, friction plays an essential role in the prosthesis stability, as it counteracts pressure 
gradient [50]. Tab.5 reports the coefficient of friction used in TAVI simulations. Exceptionally, Morganti (2014) 
does not assign friction[59]. However, the stent is vertically constrained so that it does not migrate. 
 
It is important to note that leaflets and calcifications are not always taken into account in those studies. It is 
believed that those can give support to the prosthesis [50]. Therefore, the tuning of friction coefficients by the 
different studies may come from the need to encompass the effect of the missing calcifications and leaflets over 
the support. 
Summary 
 
Studies exploit progressively more advanced constitutive material models. Some of them, however, may come 
with additional costs. For instance, complex models may require more efforts to adjust and more computational 
time. Also, more realistic models may increase the sensitivity of the simulation to other aspects which were 
previously neglected. It is suspected that the use of hyperelastic models increases the sensitivity to the initial 
geometry of the model, which should take into account the zero-pressure state. Studies are needed to clarify this 
aspect.  
 
Lastly, a hurdle to patient-specific simulation is the identification of the patient specific mechanical 
characteristics. The mechanical response of the aorta may vary from patient to patient, with different ages and 
diseases. Invasive measurement of a patient‘s aortic valve mechanical properties for simulations before TAVI 
does not seem a viable option. Efforts are made to develop methods to assess in-vivo material properties such as 
vascular elastography. Wittek et al. & Flamini et al. proposed a method to assess aorta mechanical properties 
from 4D ultrasound data[117][118]. The constitutive model parameters of patient-specific arteries can be 
obtained from inverse FE method and measurement of the artery wall strain from blood pressure changes. 
However, these methods do not seem applicable to the aortic valve yet. Different degrees of calcification may 
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also lead to very variable properties too. Thus, TAVI simulation lacks in the patient-specific material aspect. The 
choice of material model will remain a challenging question in TAVI simulation. 
3.3. Boundary conditions  
 
Boundary conditions are an important input in the model to perform reliable simulations. Like geometry of 
anatomy and mechanical properties of tissues, the complexity of human physiologic conditions does not allow 
exact representation in the simulations. This is even more evident in patient-specific cases, where a lot of 
parameters are inaccessible. Therefore, it is often necessary to assume the physiological conditions to define 
simplified boundary conditions. This aspect of simulation may be the most arbitrary, because there is a very 
broad range of possibilities to define boundary conditions. Depending on the focus of the simulation study, 
hypotheses concerning the boundary conditions must be taken accordingly. In the present review article, we will 
focus on TAV deployment conditions.  
Surrounding tissues 
 
TAVI simulations only consider a small portion of anatomy: the aortic valve. However, the valve is, in reality, 
connected to surrounding tissues. It is necessary to define how the modeled valve interacts with the external 
environment that is excluded from the simulation model. In the case of TAVI simulation, there is no consensus 
about boundary conditions applied on the extremities of the geometry. Capelli et al.[51]constrains every degree 
of freedom of the nodes along the extremities, fixing in space the ends of the model. Morganti et 
al.[59]constrains the aorta and the balloon to not move vertically. However nodes can move radially. Wang et al. 
[52]expands the geometry zone to the myocardium. Only the upper edge of the aorta (distal side) is constrained 
in all translations. In other words, we observe either totally fixed nodes, or plane-constrained nodes. However, 
when experimental data are observed, more complex details appear. The same way the arteries bear 
circumferential pre-stress, they also bear axial pre-stretch [119]. In studies of aortic valve motion, we observe 
more varied conditions. Labrosse et al. imposed an axial pre-stretch by prescribing axial displacement to the 
distal edge[82]. So far, TAVI studies neglected the interaction between the aortic wall and the surrounding 
tissues. Only the extremities of the model were considered, but it must be kept in mind that those interactions 
may have to be modeled. Sturla et al. suggested to wrap the aortic root with a virtual fully recoverable foam, the 
external surface of the foam being fixed[87].  
Blood flow 
 
TAVI studies usually concern classical solid FE analysis, so they do not take into consideration the fluid 
dynamics. The usual approach to model blood interaction is the use of spatially uniform prescribed pressure. The 
in-vivo aortic wall is constantly loaded with a minimal blood pressure. However, no simulation of TAVI 
included this pressure. Wang et al. [52]justified the omission of blood pressure by the decrease of blood pressure 
during rapid pacing (heart burst stimulation) during deployment. The study suggested that pressure decreases 
from 80-120mmHg down to 0-20mmHg. Nonetheless, the reported experimental decrease of pressure is smaller 
than this estimate: from 62-94 mmHg down to 34-64 mmHg [120]. 
 
In the case that prosthesis action is also studied, it is necessary to model the transvalvular pressure. The usual 
method is applying a uniform pressure on the surface of the TAV leaflets. Sirois et al.[8] and Auricchio et al. 
[57] prescribed pressure only on the leaflets to determine the motion of the leaflets and the closed state 
respectively. The review of Sun et al. and the studies of Marom et al. and Sturla et al. explained the merit of 
using FSI simulation compared to FE ―dry‖ models[89][84][87]. For example, the momentum of blood flow 
produces a closing impulse that is not modeled in ―dry‖ FE [76]. The prosthesis leaflets may be overly opened 
when simulating systole. The blood flow model grants damping that smooth the movement of the leaflets.  
 
Deployment steps& Balloon expansion 
 
An efficient and reliable simulation requires modeling boundary conditions as closely as necessary to the real 
conditions of the procedure. Deployment is usually composed of two steps. The crimping of the stent consists in 
compressing the stent so that its size fits in the arteries. Then, a balloon inside the prosthesis expands it (in the 
case of SAPIEN). Little to no data is given about the method to center the balloon during deployment. It seems 
that a number of studies arbitrarily align the balloon in the center of the valve. In practice, the balloon centers 
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itself during expansion. However, the boundary conditions at the edge of geometry are often in total constraint, 
so they likely prevent the balloon from ‗auto-centering‘. As previously stated, current models focus on the 
results of the deployment, such as stresses and deformations. It does not matter that the prosthesis does not take a 
realistic path during the deployment, as long as the prosthesis is correctly positioned in the end of simulation. 
However, a more realistic description of the boundary conditions of the balloon could allow realistic simulation 
of the migrations which may occur during deployment. 
 
The models of the balloon expansion in simulation studieswere relatively simple for a long time. However, 
recent studies suggest that the expansion model is important. Capelli et al. [51]and Auricchio et al. [57]used a 
uniform pressure expansion to deploy the balloon. Morganti et al.[59]and Wang et al. [52] initially used a plain 
cylinder. Its nodes were constrained in displacement in order to simulate the deployment. In the case of a 
CoreValve deployment, Russ et al. [54]suggested a rare method of deployment. It did not use a balloon, and 
displacements were directly applied to the stent. In order to crimp the prosthesis, the extremities of the stent 
frame were stretched. Then, the deployment consisted in squeezing the extremities. Eventually, this idea was not 
exploited in other studies. 
 
While most balloon inflations were straightforward in previous studies, Wang et al. [58]challenged the use of 
uniform pressure expansion. Instead, the balloon was inflated based on a volume variable method [121]. This 
method was originally applied to angioplasty, and focused on the transitory radial force during the expansion. It 
showed that the force is influenced more by the diameter of the balloon than by the filling pressure. In practice, 
TAVI operators do not control the pressure, but rather the injected volume inside the balloon. Furthermore, the 
operators can choose to use an oversized balloon and prosthesis, without completely filling the balloon, in order 
to facilitate deployment. That is something that may not be simulated realistically with uniform pressure. 
Summary 
 
Boundary conditions represent a very large question in numerical simulation. There is no definite answer as to 
what should be simplified or neglected and what should be accurately modeled. The method of simulation itself 
limits the choice, as FE analysis does not allow realistic models of blood flow. While it may not be a problem for 
quick balloon-expandable deployment, it may be so for self-expanding prostheses. Indeed, those prostheses 
―swim‖ along their guidewire and are constantly moving with the blood flow during the deployment. 
 
Many physiological conditions cannot be entirely grasped. Heart Burst Stimulation is not modeled at all, yet the 
geometrical model may greatly change as it contracts the muscle fibers. However, modeling the myocardium 
activation in the deployment for in-vivo tissues obviously seem a cumbersome task compared to how it may 
benefit to the accuracy of the simulation. Moreover, accurate descriptions of deployment tools are missing in the 
current studies, such as the guidewire of the TAV. Balloons are always spatially fixed, while in practice they are 
free to move along their guidewire. Hence, current studies completely neglect the aspect of deployment where 
the prosthesis is liable to migrate. However small, the prosthesis migration has different degrees across the 
different type of prosthesis. Medical teams are interested in it to plan their prosthesis delivery[28]. 
 
4. Data analysis 
4.1. Simulation outputs 
 
The stresses induced on the aortic wall are relevant to assess the risk of aortic injury, and were often 
reported[51][52][57][59][60]. Stresses on the stent are also relevant as they may be related to the prosthesis 
durability. Also, contact force between the stent and the aortic wall is relevant to assess the risk of migration of 
the prosthesis. However, patient-specific simulation did not systematically report contact force.  
 
An important result of simulation is the final shape of the geometries. Wang et al. [52][58]and Morganti et al. 
[59]reported the gaps between the deployed stent and the aortic wall. Indeed, these gaps are crucial to predicting 
paravalvular leaks. Morganti et al.[59]showed that those leaks could be estimated for the case of two patients, by 
observing their retrograde blood flow. 
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When calcified native leaflets are modeled, the observation of their final shape can inform clinicians on the 
occurrence of coronary occlusion. Indeed, coronary occlusion sometimes happens from the displacement of 
bulky calcified leaflets over the coronary ostium [6]. 
 
The final shape of the stent also greatly impacts the behavior of the prosthesis leaflets [43]. The behavior of the 
leaflets determines the stress distribution and the transvalvular leaks. Transvalvular leaks are believed to be 
related to the coaptation area between the leaflets during diastole. Auricchio et al. [57]and Gunning et al. 
[60]simulated the valve closure at diastole by prescribing pressure at each side of the leaflets.  
 
Clinicians usually evaluate the severity of stenosis through pressure gradient, which is the difference of pressure 
at both sides of the valve. Sirois et al.[8] and Capelli et al. [51]suggested measuring the geometric orifice area of 
the aortic valve before and after deployment of the prosthesis. Sadly, the conditions of measurement were not 
specified. Subsequent patient-specific TAVI simulations dropped this aspect. While geometric area has a strong 
correlation with energy loss at systole, a more precise fluid mechanics simulation of the implanted prosthesis 
could be relevant during the whole cardiac cycle. Sirois et al.[8]computed turbulent kinetic energy from CFD 
simulation. 
 
One of the interests of simulating deployment without focusing on the starting deployment position is the search 
for the optimal position of the landing site. Several studies tested several positions of implantation and compared 
their performances. Capelli et al.[51]showed that geometric orifice area could vary according to the implantation 
depth. Auricchio et al. [57]compared two extreme positions of prosthesis in terms of aortic wall stress, TAV 
leaflets stress, and coaptation area. There is no CFD study on this aspect yet. However, Groves et al. showed 
through experimental setup that the position of TAV had an impact on the flow[62]. The position of the valve 
changed the aortic wall stress and residence time of blood particles in the aortic root. It is speculated that the 
residence time of blood within the aortic root also influenced the coronary perfusion. Those studies on the 
optimal position of prosthesis pave the way towards the use of patient-specific simulation for clinical planning. 
 
Dwyer et al. [50]expressed concern over the orientation of the TAV prosthesis. Indeed, it has a free axis of 
rotation, as it may rotate around its guidewire, c.f. Fig.14. Gunning et al.[60]studied the impact of this 
orientation on the prosthesis. 
 
 
Fig.14 Upper view of aortic valve, orientation of prosthesis compared to sinus configuration 
 
 
4. 2. Perspectives 
 
Currently, the presented parameters already offer interesting insight to clinicians. There is no doubt that they can 
still be further developed. Some examples are given in this section. 
 
The native leaflets are tied and aligned at the base of a sinus, which plays a role in the normal function of the 
valve (c.f. Fig.14). The sinus shape evens out the stress, and helps the valve closure during diastole [69][77][79]. 
The impact of orientation on the motion of leaflets has not been studied yet. 
 
Atrioventricular Block is supposed to be related to the stress distribution on the aortic wall. Larger models to 
obtain a precise map of stresses would help predicting this complication. 
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Current models of TAV post-operative action are still lacking as it was partially treated very recently by very 
few studies. As mentioned in the boundary condition section, FE ―dry‖ simulation neglects the aortic wall 
deformation and focuses on a specific phase of the cardiac cycle, while differences in deformation between the 
wall and the stent may result in unwanted friction. 
 
Conclusion 
 
TAVI simulations are still in an active period as new studies offer increasingly accurate models. Models 
significantly differ from each other, from the choice in geometry, mechanical properties and boundary 
conditions. Current studies lack statistical data to firmly justify those choices. Therefore they may not be reliable 
enough to offer precise quantitative estimations, though they can help medical teams [58]. Precaution is still 
needed when applying current models to clinical use. 
 
Current patient-specific simulations put an emphasis on the end of deployment step and prosthesis action. 
However, they do not tackle the placement shift and migration that occur during deployment. Yet, these are 
major issues in TAVI as misplacement can have catastrophic outcomes, e.g. coronary occlusion, supra-skirtal 
leaks, and ventricle migration. Choosing the best starting positions for the deployment is a big concern for 
medical teams, especially in cases in which the deployment mechanism does not allow for recapture of the 
prosthesis or is difficult to predict. Thus, numerous challenges are awaiting patient-specific simulations. 
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Annexes 
 
Study Patient-
specific 
Subject TAVI step Deployment 
type 
Dwyer 
2009 [50] 
No Migration forces on TAV Post-op - 
Sun 2010 
[43] 
No Stress in leaflet and 
hemodynamics for 
elliptical TAV 
Post-op - 
Sirois 
2011 [8] 
Yes Hemodynamics before and 
after TAVI 
Deployment 
& post-op 
Balloon 
expandable 
Capelli 
2012 [51] 
Yes TAV deployment for 
valve-in- valve and 
bicuspid cases 
Deployment Balloon 
expandable 
Wang 
2012 [52] 
Yes TAV deployment Deployment Balloon 
expandable 
Hopf 2012 
[53] 
Yes Post-op stress & 
displacement extraction 
Post-op - 
Russ 2013 
[54] 
Yes TAV deployment 
sensitivity study 
Deployment Self expandable 
Tzamtzis 
2013 [55] 
No TAV radial force Deployment Both 
Kemp 
2013 [56] 
No TAV hemodynamics Post-op - 
Auricchio 
2014 [57] 
Yes TAV deployment Deployment Balloon 
expandable 
Wang 
2014 [58] 
Yes Aortic Rupture Deployment Balloon 
expandable 
Morganti 
2014 [59] 
Yes TAV deployment Deployment Balloon 
expandable 
Gunning 
2014 [60] 
Yes TAV deployment Deployment Self expandable 
Gessat 
2014 [61] 
Yes Post-op stress 
& displacement extraction 
Post-op - 
Tab.1 Simulation studies closely related to TAVI 
 
Study Type Subject Cardiac cycle 
concerned 
Krucinski 1993 [67] FE Leaflet flexure Full 
Grande-Allen 1998 
[68] 
FE Asymmetry of leaflets Diastole 
Grande-Allen 2000 
[69] 
FE Sinus & stress Diastole 
Gyaneshwar 2002 
[70] 
FE Dynamic analysis of leaflet & 
aortic root 
Full 
Howard 2003 [71] FE Dynamic analysis of leaflet & 
aortic root 
Full 
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Nicosia 2003 [72] FSI Patient-specific aortic valve 
model 
Full 
Carmody 2003 [73] FSI Valve-ventricle coupling Full 
De Hart 2003 [74] FSI Leaflet material models : fiber-
reinforced vs homogeneous 
Full 
Arcidiacono 2005 
[75] 
FE Prosthesis material : isotropic 
vs anisotropic 
Full 
Hose 2006 [76] FSI Closure impulse Diastole 
Ranga 2006 [77] FSI Sinus Full 
Weinberg 2007 [78] FE Multiscale analysis Full 
Katayama 2008 [79] FSI Sinus Full 
Viscardi 2010 [80] CFD Comparison : bicuspid vs 
tricuspid 
Full 
Conti 2010 [81] FE Dynamic FE analysis Full 
Labrosse 2010 [82] FE Dynamic FE analysis Full (shortened 
diastole) 
Koch 2010 [83] FE Leaflet material Diastole 
Marom 2012 [84] FSI Importance of FSI over ―dry‖ 
FE 
Mid-diastole 
Kemp 2013 [56] FSI Experimental validation Full 
Borazjani 2013 [85] FSI Comparison : mechanical 
prosthesis / bioprosthesis 
Full 
Marom 2013 [86] FSI Collagen fiber network 
asymmetry 
Full 
Sturla 2013 [87] FSI Comparison ―dry‖ FE / FSI Full 
Kuan 2014 [88] FSI 2D study of bicuspid valve Full 
Tab.2 Numerical simulations about motion of healthy native aortic valve 
 
Study Imaging 
software 
mesher native leaflet Calcification Prosthesis 
Sirois 2011 
[8] 
VTKPointpic
ker 
HyperMesh yes no SAPIEN 
Capelli 2012 
[51] 
Mimics ? yes yes SAPIEN 
Wang 2012 
[52] 
Avizo HyperMesh yes yes SAPIEN 
Russ 2013 
[54] 
Philips Heart 
Navigator 
ICEM CFD yes yes CoreValve 
Auricchio 
2014 [57] 
ITKsnap Matlab no no SAPIEN 
Wang 2014 
[58] 
Avizo HyperMesh yes yes SAPIEN 
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Morganti 2014 
[59] 
ITKsnap Matlab yes yes SAPIEN 
Gunning 2014 
[60] 
Mimics Abaqus no no Custom self-
expandable 
Tab.3 Conditions for geometric reconstruction in numerical models 
 
 
Study Aorta/Leaflet Calcification Prosthesis Zero-
pressure 
Sirois 2011 
[8] 
HE (Fung) [107] none ? no 
Capelli 2012 
[51] 
HE (Mooney-Rivlin) LE EP (E=193 MPa) stainless steel no 
Wang 2012 
[52] 
HE [96] LE [108] EP cobalt-chromium (E=243 GPa) yes 
Russ 2013 
[54] 
Rigid/LE/HE LE EP Nitinol no 
Auricchio 
2014 [57] 
HE [109] none EP stainless steel  no 
Wang 2014 
[58] 
HE [110] LE [111] EP stainless steel [55] ? 
Morganti 
2014 [59] 
HE [112][113] LE  EP cobalt-chromium 
(E=233GPa) 
no 
Gunning 
2014 [60] 
HE (Mooney-Rivlin) none HE Nitinol [55] no 
Tab.4 Material models used in TAVI simulations 
 
Study Friction Coefficient 
Capelli 2012 
[51] 
0.25 
Wang 2012 
[52] 
0.1 
Russ 2013 
[54] 
0.2 
Auricchio 
2014 [57] 
0.2 
Morganti 
2014 [59] 
Vertical constraint 
instead of friction 
Gunning 
2014 [60] 
0.25 
Tab.5 Coefficient of friction reported in simulation studies 
 
 
